Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carnival Corporation stock logo
CCL
Carnival
$29.33
+2.3%
$24.56
$13.78
$30.46
$34.23B2.6125.12 million shs16.14 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.36
-1.2%
$23.92
$20.92
$31.54
$144.15B0.5841.62 million shs25.89 million shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carnival Corporation stock logo
CCL
Carnival
+2.28%-0.02%+30.99%+63.05%+60.86%
Pfizer Inc. stock logo
PFE
Pfizer
-1.15%+0.50%+3.44%+12.97%-12.33%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Carnival Corporation stock logo
CCL
Carnival
4.6038 of 5 stars
2.32.00.03.13.21.74.4
Pfizer Inc. stock logo
PFE
Pfizer
4.9714 of 5 stars
3.23.04.24.52.61.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Carnival Corporation stock logo
CCL
Carnival
2.65
Moderate Buy$28.65-2.31% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.45
Hold$28.5512.60% Upside

Current Analyst Ratings Breakdown

Latest PFE and CCL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/26/2025
Carnival Corporation stock logo
CCL
Carnival
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$21.00 ➝ $24.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$28.00 ➝ $30.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$33.00 ➝ $35.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$33.00 ➝ $34.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetPositive ➝ Positive$27.00 ➝ $30.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$30.00 ➝ $31.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$30.00 ➝ $33.00
6/23/2025
Carnival Corporation stock logo
CCL
Carnival
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$33.00 ➝ $34.00
6/23/2025
Carnival Corporation stock logo
CCL
Carnival
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$27.00
6/23/2025
Carnival Corporation stock logo
CCL
Carnival
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
5/29/2025
Pfizer Inc. stock logo
PFE
Pfizer
Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold$28.00 ➝ $25.00
(Data available from 7/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Carnival Corporation stock logo
CCL
Carnival
$25.02B1.37$4.07 per share7.21$8.02 per share3.66
Pfizer Inc. stock logo
PFE
Pfizer
$62.46B2.31$4.31 per share5.88$15.62 per share1.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Carnival Corporation stock logo
CCL
Carnival
$1.92B$1.8515.8514.030.639.72%27.88%5.20%9/29/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.3818.378.370.9312.62%20.33%8.53%8/5/2025 (Estimated)

Latest PFE and CCL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/AN/AN/A$13.43 billionN/A
6/24/2025Q2 2025
Carnival Corporation stock logo
CCL
Carnival
$0.24$0.35+$0.11$0.42$6.20 billion$6.33 billion
4/29/2025Q1 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.67$0.92+$0.25$0.52$14.43 billion$13.72 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Carnival Corporation stock logo
CCL
Carnival
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.78%N/A124.64%16 Years

Latest PFE and CCL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/25/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.08%7/25/20257/25/20259/2/2025
4/23/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.69%5/9/20255/9/20256/13/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Carnival Corporation stock logo
CCL
Carnival
2.58
0.34
0.30
Pfizer Inc. stock logo
PFE
Pfizer
0.64
1.26
0.96

Institutional Ownership

CompanyInstitutional Ownership
Carnival Corporation stock logo
CCL
Carnival
67.19%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Carnival Corporation stock logo
CCL
Carnival
7.60%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
Carnival Corporation stock logo
CCL
Carnival
100,0001.17 billion1.08 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable

Recent News About These Companies

Drystone LLC Buys 16,888 Shares of Pfizer Inc. (NYSE:PFE)
Pfizer (PFE) Reports XTANDI Shows Life-Extending Benefits
Pfizer (PFE) Reports XTANDI Shows Life-Extending Benefits

New MarketBeat Followers Over Time

Media Sentiment Over Time

Carnival stock logo

Carnival NYSE:CCL

$29.32 +0.67 (+2.32%)
Closing price 07/14/2025 03:59 PM Eastern
Extended Trading
$29.27 -0.05 (-0.19%)
As of 07/14/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Pfizer stock logo

Pfizer NYSE:PFE

$25.36 -0.30 (-1.15%)
Closing price 07/14/2025 03:59 PM Eastern
Extended Trading
$25.39 +0.04 (+0.15%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.